|
Synarc's medical and scientific experts are leaders in the field, and provide you with the direct hands-on expertise, guidance and credibility necessary for the success of your clinical trials.
|
| |
 |
| |
|
Caroline Reinhold, M.D., M.Sc.
Medical Director, Oncology |
|
|
Carol S. Portlock, M.D.
Lymphoma |
| |
|
|
|
|
|
Patrick Garnero, Ph.D., D.Sc.
Vice President and General Manger, Biochemical Markers |
|
|
Phil S. Schein, M.D., F.R.C.P.
Director, Clinical Research |
| |
|
|
|
|
| |
Mark R. Green, M.D.
Lung Cancer |
|
|
Daniel O. Slosman, M.D., Ph.D.
Medical Director, Nuclear Medicine |
| |
|
|
|
|
|
Ali Guermazi, M.D.
Medical Director, Lymphoma & Renal Cancer
|
|
|
Susan F. Slovin, M.D., Ph.D.
Prostate Cancer |
| |
|
|
|
|
|
Malik E. Juweid, MD
Synarc Medical Director, PET CT |
|
|
James L. Speyer, M.D.
Breast Cancer |
| |
|
|
|
|
|
Anwar R. Padhani, M.D., Ph.D.
Associate Medical Director, Oncology |
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
